BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1139957)

  • 1. Lack of clinical contraceptive efficacy of large doses of r 2323 given before implantation or after a missed period.
    Mora G; Faúndes A; Johansson ED
    Contraception; 1975 Aug; 12(2):211-20. PubMed ID: 1139957
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of weekly administration of an oral progestogen -R 2323- on the ovarian function.
    Victor A; Johansson ED
    Contraception; 1975 Jul; 12(1):89-94. PubMed ID: 1139951
    [No Abstract]   [Full Text] [Related]  

  • 3. Contraceptive efficacy of once-weekly oral administration of 2.5 mg R 2323.
    Sakiz E; Azadian-Boulanger G; Ojasoo T; Laraque F
    Contraception; 1976 Sep; 14(3):275-84. PubMed ID: 975818
    [No Abstract]   [Full Text] [Related]  

  • 4. Contraceptive steroid administration by subdermal implants: serum concentrations of R-2323, estrogen and progesterone in rhesus monkeys.
    Bahgat MR; Atkinson LE
    Contraception; 1977 Mar; 15(3):335-45. PubMed ID: 880812
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravaginal contraception with the synthetic progestin, R2010.
    Toivonen J
    Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of midcycle contraceptive (R 2323) on the human endometrium.
    Azadian-Boulanger G; Secchi J; Laraque F; Raynaud JP; Sakiz E
    Am J Obstet Gynecol; 1976 Aug; 125(8):1049-56. PubMed ID: 782250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long acting contraceptive implants. An analysis of menstrual bleeding patterns.
    Faundes A; Sivin I; Stern J
    Contraception; 1978 Oct; 18(4):355-65. PubMed ID: 363347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive effectiveness of Silastic implants containing the progestin R-2323.
    Coutinho EM; Da Silva AR; Carreira CM; Chaves MC; Adeodato Filho J
    Contraception; 1975 Jun; 11(6):625-35. PubMed ID: 1137935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial with subdermal implants containing norgestrienone.
    Diaz S; Pavez M; Quinteros E; Diaz J; Robertson DN; Croxatto HB
    Contraception; 1978 Oct; 18(4):429-40. PubMed ID: 720075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials.
    Coutinho E; da Silva AR; Mattos CE; Nielsen NC; Osler M; Wiese J
    Contraception; 1978 Oct; 18(4):335-53. PubMed ID: 363346
    [No Abstract]   [Full Text] [Related]  

  • 11. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
    Da Silva AR; Coutinho EM
    Int J Fertil; 1978; 23(3):185-92. PubMed ID: 40892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of progesterone antagonist, lilopristone (ZK 98.734), on induction of menstruation, inhibition of nidation, and termination of pregnancy in bonnet monkeys.
    Puri CP; Katkam RR; D'Souza A; Elger WA; Patil RK
    Biol Reprod; 1990 Sep; 43(3):437-43. PubMed ID: 2271724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III and oral contraception with progestagen-only preparation.
    Conard J; Samama M; Horellou MN; Zorn JR; Neau C
    Lancet; 1979 Sep; 2(8140):471. PubMed ID: 89530
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hormonal anovulation with a single monthly oral dose].
    Palomo A; Caballero A; Jáñez J; Sainz-Pardo F
    Tokoginecol Pract; 1976 May; 35(384):547-64. PubMed ID: 1014005
    [No Abstract]   [Full Text] [Related]  

  • 15. Subcutaneous bioabsorbable pellets of norethindrone for contraception in women: Phase I. Clinical study.
    Gupta GN; Saxena BB; Landesman R; Ledger WJ
    Fertil Steril; 1984 May; 41(5):726-31. PubMed ID: 6714449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norethisterone contraceptive microspheres.
    Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
    J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructure of human uterine epithelium at the time of implantation after postovulatory administration of norethindrone.
    Nilsson O; Nygren KG
    Ups J Med Sci; 1974; 79(2):65-71. PubMed ID: 4837833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormone regulation of male fertility].
    Anselmo JG
    Rev Chil Obstet Ginecol; 1975; 40(3):113-21. PubMed ID: 1230868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postcoital contraception with steroid hormones].
    Köhler G; Göretzlehner G
    Zentralbl Gynakol; 1984; 106(17):1173-81. PubMed ID: 6437101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.